Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-02-02 @ 6:20 PM
Study NCT ID:
NCT01668966
Status:
COMPLETED
Last Update Posted:
2019-05-13
First Post:
2012-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12-09
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-16
First Submit QC Date:
None
Study First Post Date:
2012-08-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-30
Results First Submit QC Date:
None
Results First Post Date:
2019-05-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-11
Last Update Post Date:
2019-05-13
Last Update Post Date Type:
ACTUAL